Inocras Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
40
- Latest Deal Type
-
Series B3
- Latest Deal Amount
-
$31M
- Investors
-
27
Inocras General Information
Description
Developer of a genome-based big data platform designed to pave the way for a new era of personalized precision medicine. The company's platform offers insights through the precise interpretation of full-length genome big data, enabling clients to employ the information effectively in their operations.
Contact Information
Website
www.inocras.comCorporate Office
- 6330 Nancy Ridge Drive
- Suite 106
- San Diego, CA 92121
- United States
Corporate Office
- 6330 Nancy Ridge Drive
- Suite 106
- San Diego, CA 92121
- United States
Inocras Timeline
Inocras Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series B3) | 03-Aug-2026 | $31M | Completed | Generating Revenue | ||
| 5. Later Stage VC | 01-Jun-2025 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B2) | 01-Nov-2023 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 27-Apr-2022 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 29-Nov-2020 | $5.7M | $5.7M | Completed | Generating Revenue | |
| 1. Grant | 01-Jan-2020 | $300K | Completed | Startup |
Inocras Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B2 | ||||||||
| Series B | ||||||||
| Series A2 | 11,464,000 | $0.000100 | 0.1% | $0.48 | $0.48 | 1x | $0.48 | 13.13% |
| Series A1 | 2,222,200 | $0.000100 | 0.1% | $0.15 | $0.15 | 1x | $0.15 | 2.55% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Inocras Comparisons
Industry
Financing
Details
Inocras Competitors (3)
One of Inocras’s 3 competitors is Geneious, a Formerly PE-Backed company based in Auckland, New Zealand.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Geneious | Formerly PE-Backed | Auckland, New Zealand | ||||
| Illumina | Formerly VC-backed | San Diego, CA | ||||
| Sequentia Biotech | Venture Capital-Backed | Barcelona, Spain |
Inocras Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Inocras Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Inocras Investors (27)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aimedbio | Corporation | Minority | ||
| DT & Investment | Corporate Venture Capital | Minority | ||
| IMM Investment | Asset Manager | Minority | ||
| Korea Investment & Securities | Asset Manager | Minority | ||
| Loftyrock Investment | Venture Capital | Minority |
Inocras FAQs
-
When was Inocras founded?
Inocras was founded in 2020.
-
Where is Inocras headquartered?
Inocras is headquartered in San Diego, CA.
-
What is the size of Inocras?
Inocras has 40 total employees.
-
What industry is Inocras in?
Inocras’s primary industry is Laboratory Services (Healthcare).
-
Is Inocras a private or public company?
Inocras is a Private company.
-
What is Inocras’s current revenue?
The current revenue for Inocras is .
-
How much funding has Inocras raised over time?
Inocras has raised $82.7M.
-
Who are Inocras’s investors?
Aimedbio, DT & Investment, IMM Investment, Korea Investment & Securities, and Loftyrock Investment are 5 of 27 investors who have invested in Inocras.
-
Who are Inocras’s competitors?
Geneious, Illumina, and Sequentia Biotech are competitors of Inocras.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
